Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.
Clinical trial NCT00738595 · COMPLETED
Trial details
- NCT number
- NCT00738595
- Sponsor
- Evotec Neurosciences GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-03-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.